[Internet and amyotrophic lateral sclerosis treatment: what is wrong?].
Meininger
V
V
Antoine
J-C
JC
Arne-Bes
M C
MC
Broussolle
E
E
Bruneteau
G
G
Camdessanche
J P
JP
Camu
W
W
Carluer
L
L
Cintas
P
P
Clavelou
P
P
Corcia
P
P
Couratier
P
P
Danel-Brunaud
V
V
Desnuelle
C
C
Destée
A
A
Dib
M
M
Fleury
M-C
MC
Furby
A
A
Giroud
M
M
Gonzales
J
J
Guy
N
N
Kolev
I
I
Lacomblez
L
L
Lardillier-Noel
D
D
Le Forestier
N
N
Maugin
D
D
Nicolas
G
G
Pittion
S
S
Pouget
J
J
Pradat
P F
PF
Rousso
E
E
Salachas
F
F
Soriani
M H
MH
Tranchant
C
C
Vandenberghe
N
N
Verschueren
A
A
Viader
F
F
Vial
C
C
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D017277:Drug Approval; D004353:Drug Evaluation, Preclinical; D005602:France; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use*; D036341:Intercellular Signaling Peptides and Proteins / Q000627:therapeutic use*; D020407:Internet; D018020:Lithium Compounds / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D036341:Intercellular Signaling Peptides and Proteins; D018020:Lithium Compounds; C065700:myotrophin; D007334:Insulin-Like Growth Factor I